Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492512 · ClinicalTrials.gov registry record · Phase 4
Oral Iron Supplementation on Alternate Vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
A Phase 4 study of Pregnancy and Iron-deficiency Anemia (IDA), sponsored by Southern Illinois University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06492512 is a Phase 4 study of Pregnancy and Iron-deficiency Anemia (IDA) that is actively recruiting participants, run by Southern Illinois University. The registered enrollment target is 120 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06492512, a Phase 4 study of Pregnancy and Iron-deficiency Anemia (IDA), is actively recruiting participants, sponsored by Southern Illinois University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.
Conditions Studied
Interventions
- DRUG daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
- DRUG alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
Study Locations (1)
Illinois
- Southern Illinois University School of Medicine - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-12 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06492512
The ClinicalTrials.gov registry entry for NCT06492512 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (86% lower). The listed sponsor is Southern Illinois University, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill is the first listed.
NCT06492512 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06492512 about?
NCT06492512 is a clinical study titled "Oral Iron Supplementation on Alternate Vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy". This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.
What is the current status of trial NCT06492512?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2024-12. Estimated completion is 2028-06-30.
What conditions does trial NCT06492512 study?
This clinical trial studies the following conditions: Pregnancy, Iron-deficiency Anemia (IDA).
What interventions are being tested in trial NCT06492512?
The interventions under investigation include: daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill (DRUG), alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill (DRUG).
Who is sponsoring clinical trial NCT06492512?
This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06492512 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
COMPLETED · Phase 4
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.